A cohort study found that nearly three fourths of infants received respiratory syncytial virus protection with either nirsevimab or through exposure to maternal RSVpreF in the 2023-2024 season.
What should you know about RSV and who can get it? In many cases, there is a difference for adults and children, ...
Hosted on MSN4d
Understanding RSV: Symptoms, risks, and preventionDr. Iris Gorfinkel joins us to discuss RSV, a highly contagious respiratory virus that’s becoming more prominent this winter.
Respiratory syncytial virus is a common, highly contagious illness that often causes mild upper respiratory symptoms, akin to a cold. In babies, particularly those with tiny airways, RSV can cause the ...
When existing systems do not accommodate access to health care innovation, we must change those systems. Fulfilling nirsevimab’s promise will require overcoming entrenched hospital payment norms.
The panel of vaccine experts were supposed to hold their first meeting under the Trump administration in late February. It's ...
Older adults' immune systems naturally weaken with age, making them more susceptible to COVID-19, influenza (flu) and RSV. Here's what you need to know about these respiratory viruses and why ...
Prior to vaccine availability, RSV was a significant cause of illness and hospitalization in older adults in the U.S., ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results